• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21804 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     University HealthSystem Consortium (UHC) Nesiritide update
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of infliximab for Crohn's disease
2002     Institute for Clinical Systems Improvement (ICSI) Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC)
2002     University HealthSystem Consortium (UHC) COX-2 update
2002     HAYES, Inc. Excimer laser coronary angioplasy
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of atypical antipsychotics for schizophrenia
2002     Institute for Clinical Systems Improvement (ICSI) High-dose chemotherapy with autologous stem cell support for the treatment of breast cancer
2002     University HealthSystem Consortium (UHC) Bevacizumab
2002     HAYES, Inc. External counterpulsation
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of anti-D prophylaxis for rhesus negative women in pregnancy
2002     Institute for Clinical Systems Improvement (ICSI) Home uterine activity monitoring for detection of preterm labor
2002     University HealthSystem Consortium (UHC) Adalimumab
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of human growth hormone in children with growth failure
2002     University HealthSystem Consortium (UHC) 5-HT1 agonists for migraine - update
2002     Agency for Healthcare Research and Quality (AHRQ) Training of clinicians for public health events relevant to bioterrorism preparedness
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of pegylated liposomal doxorubicin hydrochloride (Caelyx) for ovarian cancer
2002     University HealthSystem Consortium (UHC) Omalizumab
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of metal on metal hip resurfacing
2002     University HealthSystem Consortium (UHC) Gene therapy
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Four-dimensional ultrasound for prenatal diagnosis
2002     The Swedish Council on Health Technology Assessment (SBU) Cardiac pumps in treating chronic heart failure - early assessment briefs (ALERT)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of surgery to aid weight reduction for people with morbid obesity
2002     Institute for Clinical Systems Improvement (ICSI) Intracoronary brachytherapy to treat restenosis after stent placement (in-stent restenosis)
2002     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Evaluation of TVT (tension-free vaginal tape) in female stress urinary incontinence
2002     Agency for Healthcare Research and Quality (AHRQ) Thoracic electrical bioimpedance
2002     HAYES, Inc. Fecal DNA testing for colorectal cancer screening and monitoring
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of ultrasound locating devices for placing central venous lines
2002     Institute for Clinical Systems Improvement (ICSI) Intradiscal electrothermal therapy (IDET) for low back pain
2002     HAYES, Inc. Female urinary incontinence treatment, nonsurgical devices
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Guidance on the use of glycoprotein IIb/IIIa inhibitors
2002     Institute for Clinical Systems Improvement (ICSI) Left ventricular assist devices as permanent implants
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Home compared with hospital haemodialysis for patients with end-stage renal failure
2002     Institute for Clinical Systems Improvement (ICSI) Lymphatic mapping with sentinel lymph node biopsy for breast cancer
2002     HAYES, Inc. Fetoscopic laser surgery for twin-twin transfusion syndrome
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of imatinib for chronic myeloid leukaemia
2002     Basque Office for Health Technology Assessment (OSTEBA) [The identification of emerging health technologies. Document for the SorTek network]
2002     The Swedish Council on Health Technology Assessment (SBU) Endoscopic transthoracic sympathectomy (ETS) - early assessment briefs (ALERT)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Organisation of services for diabetic retinopathy screening: HTA Advice 1: Organisation of services for diabetic retinopathy screening: Understanding HTBS Advice: Diabetic retinopathy screening in Scotland
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of computerized cognitive-behavioural therapy for anxiety and depression
2002     The Swedish Council on Health Technology Assessment (SBU) Endovascular surgery for abdominal aortic aneurysm - early assessment briefs (ALERT)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Positron emission tomography (PET) imaging in cancer management; HTA Advice 2: Positron emission tomography (PET) imaging in cancer management; Understanding HTBS Advice; Use of PET imaging for cancer in Scotland. Amendment to full report published July 2005.
2002     Institute for Clinical Systems Improvement (ICSI) Pancreatic islet transplantation for patients with type 1 diabetes mellitus
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of drugs for early thrombolysis in the treatment of acute myocardial infarction
2002     WorkSafeBC Marijuana for medicinal purposes: an evidence-based assessment
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Injury in Israel
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Sex change surgery - expert panel. IPE-02/i
2002     HAYES, Inc. Gastric electrical stimulation for gastroparesis
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of long-acting insulin analogues for the treatment of diabetes - insulin glargine
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Medical management of terrorist attacks
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of vinorelbine for the treatment of advanced breast cancer
2002     The Swedish Council on Health Technology Assessment (SBU) Pallidotomy in Parkinson's disease - early assessment briefs (ALERT)
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) When is an epidemic an epidemic?
2002     Institute for Clinical Systems Improvement (ICSI) Photodynamic therapy for head and neck, tracheobronchial, and esophageal cancer
2002     Institute for Clinical Effectiveness and Health Policy (IECS) AMS 800 artificial urinary sphincter for children with urinary incontinence
2002     The Swedish Council on Health Technology Assessment (SBU) The ketogenic diet for epilepsy - early assessment briefs (ALERT)
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Diabolocal, haunting terror - here and now
2002     Institute for Clinical Systems Improvement (ICSI) Prenatal ultrasound as a screening test
2002     Andalusian Health Technology Assessment Area (AETSA) Appropriate use of short-cycle sterilization (flash sterilization) in non-urgent ophthalmological surgery - non-systematic review
2002     HAYES, Inc. Genetic testing for susceptibility to breast cancer
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of beta interferon and glatiramer acetate for the treatment of multiple sclerosis
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Hospital management of a bioterror event
2002     Institute for Clinical Systems Improvement (ICSI) Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2002     Andalusian Health Technology Assessment Area (AETSA) Report on the hearing-aid device AUDIGITAL ALFA 128
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer
2002     Medical Services Advisory Committee (MSAC) Liquid based cytology for cervical screening
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of trastuzumab for the treatment of advanced breast cancer
2002     Medical Services Advisory Committee (MSAC) Human papillomavirus testing in women with cytological prediction of low-grade abnormality
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis
2002     Medical Services Advisory Committee (MSAC) Intravascular brachytherapy
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis
2002     Medical Services Advisory Committee (MSAC) Magnetic resonance imaging for cholangeopancreatography
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Air travel as a risk factor for venous thromboembolism (VTE) and the effectiveness of preventive measures
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma (replaced by TA137)
2002     Medical Services Advisory Committee (MSAC) Percutaneous transluminal coronary rotational atherectomy for lesions of the coronary arteries
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Carotid stenting for the treatment of carotid artery stenosis
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Expandable metal stents for inoperable oesophageal cancer
2002     National Institute for Clinical Excellence (NICE) Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years)
2002     Medical Services Advisory Committee (MSAC) Recombinant human thyroid-stimulating hormone (rhTSH). Diagnostic agent for use in well-differentiated thyroid cancer
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Deep brain stimulation for patients with Parkinson's disease
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Fludarabine as first line therapy for chronic lymphocytic leukaemia
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Photonic stimulation for the treatment of chronic pain
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of infliximab for Crohn's disease
2002     Medical Services Advisory Committee (MSAC) Transoesophageal echocardiography
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Spinal manipulation for lower back pain
2002     National Institute for Clinical Excellence (NICE) Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women
2002     Medical Services Advisory Committee (MSAC) Selective internal radiation therapy for hepatic metastases using SIR-Spheres(R)
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2002     Medical Services Advisory Committee (MSAC) M-VAX(TM) - a treatment for patients with advanced stage III melanoma
2002     NIHR Health Technology Assessment programme Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Assessment of the effectiveness of health promotion and disease prevention technologies. IPE-02/36 (Public report)
2002     NIHR Health Technology Assessment programme Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Beta-interferon and glatiramer acetate for the treatment of multiple sclerosis
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
2002     NIHR Health Technology Assessment programme The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review
2002     ECRI Helical CT for detection of lung cancer
2002     Agency for Healthcare Research and Quality (AHRQ) Current validity of AHRQ clinical practice guidelines
2002     NIHR Health Technology Assessment programme Promoting physical activity in South Asian Muslim women through 'exercise on prescription'
2002     NIHR Health Technology Assessment programme A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models
2002     ECRI High-dose chemotherapy and stem cell transplantation for the treatment of systemic lupus erythematosus